Ed Harlow

28.1k total citations · 14 hit papers
144 papers, 24.0k citations indexed

About

Ed Harlow is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ed Harlow has authored 144 papers receiving a total of 24.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 63 papers in Oncology and 37 papers in Genetics. Recurrent topics in Ed Harlow's work include Cancer-related Molecular Pathways (46 papers), Virus-based gene therapy research (35 papers) and Ocular Oncology and Treatments (19 papers). Ed Harlow is often cited by papers focused on Cancer-related Molecular Pathways (46 papers), Virus-based gene therapy research (35 papers) and Ocular Oncology and Treatments (19 papers). Ed Harlow collaborates with scholars based in United States, United Kingdom and Canada. Ed Harlow's co-authors include Nicholas J. Dyson, Peter Whyte, Karen Buchkovich, Karl Münger, Peter M. Howley, Sander van den Heuvel, Li‐Huei Tsai, Matthew Meyerson, David A. Lane and Marie Classon and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Ed Harlow

139 papers receiving 23.2k citations

Hit Papers

The Human Papilloma Virus... 1981 2026 1996 2011 1989 1988 1981 1993 1989 500 1000 1.5k 2.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ed Harlow 15.5k 12.6k 5.8k 3.2k 2.7k 144 24.0k
Nicholas J. Dyson 15.1k 1.0× 11.9k 0.9× 3.4k 0.6× 2.8k 0.9× 3.5k 1.3× 142 22.5k
James A. DeCaprio 13.0k 0.8× 11.3k 0.9× 3.7k 0.6× 2.0k 0.6× 1.6k 0.6× 208 21.4k
David M. Livingston 30.8k 2.0× 16.1k 1.3× 10.6k 1.8× 3.0k 0.9× 1.7k 0.6× 251 41.4k
Kristian Helin 31.3k 2.0× 9.1k 0.7× 4.6k 0.8× 2.0k 0.6× 1.3k 0.5× 275 37.0k
Anton Berns 13.5k 0.9× 9.6k 0.8× 3.1k 0.5× 1.2k 0.4× 2.3k 0.9× 211 23.7k
Martine F. Roussel 19.4k 1.3× 12.4k 1.0× 2.6k 0.4× 2.9k 0.9× 1.2k 0.4× 242 27.9k
Steven I. Reed 22.7k 1.5× 11.3k 0.9× 2.4k 0.4× 7.8k 2.4× 1.2k 0.4× 208 27.3k
Scott W. Hiebert 14.1k 0.9× 5.4k 0.4× 2.2k 0.4× 1.5k 0.5× 1.0k 0.4× 176 19.1k
Glenn Merlino 10.9k 0.7× 6.1k 0.5× 2.6k 0.4× 2.2k 0.7× 1.0k 0.4× 215 17.9k
Frédéric J. de Sauvage 17.7k 1.1× 8.0k 0.6× 4.7k 0.8× 1.6k 0.5× 1.8k 0.7× 148 31.0k

Countries citing papers authored by Ed Harlow

Since Specialization
Citations

This map shows the geographic impact of Ed Harlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Harlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Harlow more than expected).

Fields of papers citing papers by Ed Harlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Harlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Harlow. The network helps show where Ed Harlow may publish in the future.

Co-authorship network of co-authors of Ed Harlow

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Harlow. A scholar is included among the top collaborators of Ed Harlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Harlow. Ed Harlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tschöp, Katrin, Andrew R. Conery, Larisa Litovchick, et al.. (2011). A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes & Development. 25(8). 814–830. 97 indexed citations
2.
Harlow, Ed & David P. Lane. (2006). Immunoprecipitation: Purifying the Immune Complexes. Cold Spring Harbor Protocols. 2006(4). pdb.prot4536–pdb.prot4536. 4 indexed citations
3.
Pearlberg, Joseph, Sébastien Degot, Wilson O. Endege, et al.. (2005). Screens Using RNAi and cDNA Expression as Surrogates for Genetics in Mammalian Tissue Culture Cells. Cold Spring Harbor Symposia on Quantitative Biology. 70(0). 449–459. 22 indexed citations
4.
Barbie, David A., Brian A. Kudlow, Richard L. Frock, et al.. (2003). Nuclear Reorganization of Mammalian DNA Synthesis Prior to Cell Cycle Exit. Molecular and Cellular Biology. 24(2). 595–607. 30 indexed citations
5.
Fingar, Diane C., et al.. (2002). Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes & Development. 16(12). 1472–1487. 872 indexed citations breakdown →
6.
McCaffrey, Jennifer, Lili Yamasaki, Nicholas J. Dyson, Ed Harlow, & Anne E. Griep. (1999). Disruption of Retinoblastoma Protein Family Function by Human Papillomavirus Type 16 E7 Oncoprotein Inhibits Lens Development in Part through E2F-1. Molecular and Cellular Biology. 19(9). 6458–6468. 34 indexed citations
7.
Bartley, Stephanie M., Carrie R. Graveel, Nicholas J. Dyson, et al.. (1999). No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice. Molecular Carcinogenesis. 25(4). 295–303. 18 indexed citations
8.
Dynlacht, Brian David, Kenneth H. Moberg, Jacqueline A. Lees, Ed Harlow, & Liang Zhu. (1997). Specific Regulation of E2F Family Members by Cyclin-Dependent Kinases. Molecular and Cellular Biology. 17(7). 3867–3875. 98 indexed citations
9.
Yamasaki, Lili, Tyler Jacks, Roderick T. Bronson, et al.. (1996). Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1. Cell. 85(4). 537–548. 603 indexed citations breakdown →
10.
Wu, Chin‐Lee, et al.. (1995). In Vivo Association of E2F and DP Family Proteins. Molecular and Cellular Biology. 15(5). 2536–2546. 210 indexed citations
11.
Koh, James, Greg H. Enders, Brian David Dynlacht, & Ed Harlow. (1995). Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature. 375(6531). 506–510. 444 indexed citations
12.
Wade, Michael S., Michael C. Blake, Robert Jambou, et al.. (1995). An Inverted Repeat Motif Stabilizes Binding of E2F and Enhances Transcription of the Dihydrofolate Reductase Gene. Journal of Biological Chemistry. 270(17). 9783–9791. 30 indexed citations
13.
Fattaey, Ali, Ed Harlow, & Kristian Helin. (1993). Independent Regions of Adenovirus E1A are Required for Binding to and Dissociation of E2F-Protein Complexes. Molecular and Cellular Biology. 13(12). 7267–7277. 46 indexed citations
14.
Cao, Liang, Barbara Faha, Marlene Dembski, et al.. (1992). Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature. 355(6356). 176–179. 336 indexed citations
15.
Meyerson, Matthew, Barbara Faha, Lijuan Su, Ed Harlow, & Li‐Huei Tsai. (1991). The Cyclin-dependent Kinase Family. Cold Spring Harbor Symposia on Quantitative Biology. 56(0). 177–186. 23 indexed citations
16.
Dyson, Nicholas J., Karen Buchkovich, Peter Whyte, & Ed Harlow. (1989). The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell. 58(2). 249–255. 268 indexed citations
17.
Buchkovich, Karen, Linda Duffy, & Ed Harlow. (1989). The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell. 58(6). 1097–1105. 892 indexed citations breakdown →
18.
Whyte, Peter, et al.. (1989). Cellular targets for transformation by the adenovirus E1A proteins. Cell. 56(1). 67–75. 690 indexed citations breakdown →
19.
Whyte, Peter, Karen Buchkovich, Jonathan M. Horowitz, et al.. (1988). Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature. 334(6178). 124–129. 1219 indexed citations breakdown →
20.
Harlow, Ed, Peter Whyte, B. Robert Franza, & Carol Schley. (1986). Association of Adenovirus Early-Region 1A Proteins with Cellular Polypeptides. Molecular and Cellular Biology. 6(5). 1579–1589. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026